Melanoma in Practice: Nurse Conference

Melanoma in Practice: Nurse Conference

26 July 2018

It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.  Designed specifically for nurses, the presentations were designed to give nurses a better understanding of the patient experience from detection through to treatment of advanced disease and included updates in the latest areas of research that are changing the way we treat melanoma.

Presentations were given by melanoma specialists in dermatology, pathology, medical oncology, surgery, radiotherapy, physiotherapy, psychology and clinical trials, as well as melanoma survivors and CNCs who are directly involved in melanoma care

Highlights included a presentation from Associate Professor Robyn Saw who discussed the processes of surgical management of melanoma Stages 0-IV and how “understanding the anatomy is essential for diagnosing and treating melanoma”. 

A key takeaway from the conference was a presentation by Associate Professor Matteo Carlino. Associate Professor Carlino delved into the system therapy for the treatment of advanced melanoma and notably pointed out how there has been a shift in nurses’ role in melanoma.  “It used to be that advanced melanoma nurses worked primarily on palliative care. We're now in a time where nurses are working on survivorship care”, said Associate Professor Carlino, a statement that really resonated with the audience.

We’d like to thank those who attended and engaged with the conference. One attendee said that ‘all the sessions were so informative and the presenters had a real passion for their work’ and we hope that all attendees found it both enjoyable and beneficial.

The presentations from the Nurse Conference will be made available on our free melanoma education portal for healthcare practitioners in the next few weeks.  If you’re a nurse, we encourage you to register your interest at www.melanomaeducation.org.au to be the first to know when they become available.

Sunbed campaigner acknowledged as one of most influential Australians
17 Dec 2014

Sunbed campaigner acknowledged as one of most influential Australians

Sunbed campaigner, Jay Allen, has been acknowledged on the honour roll of Australia’s most influential people in the non-profit sector.

A world-class organisation needs a world-class website
03 Dec 2014

A world-class organisation needs a world-class website

Today we launch the website we’ve dreamed about!

Watch Your Mate's Back kicks off
01 Dec 2014

Watch Your Mate's Back kicks off soon

Our new summer campaign has you and your mates' backs covered!

Saving our next generation
18 Nov 2014

Saving our next generation

Researcher James Wilmott is working to fill a gap in research for young patients.

It's time to march for a cure!
17 Nov 2014

It's time to march for a cure!

Join us for our fourth annual Melanoma March and help us raise over $1 million for melanoma research as we march for a cure! 

Making a difference
17 Nov 2014

Making a difference

When Melanoma Institute Australia (MIA) patients at the Poche Centre are first diagnosed with advanced melanoma Anna Hoadley is there.

New trial offers hope to Stage IV patients
17 Nov 2014

New trial offers hope to Stage IV patients

Shining new hope for patients with advanced stage melanoma.

Combination drug therapy halts disease in advanced melanoma
29 Sep 2014

Combination drug therapy halts disease in advanced melanoma

A world-first study in the New England Journal of Medicine heralds the effectiveness of a targeted combination drug therapy after reporting major declines in the risk of disease progression and death in people with metastatic melanoma.

Georgina Long wins award for Outstanding Cancer Research
22 Aug 2014

Georgina Long wins award for Outstanding Cancer Research

Associate Professor Georgina Long wins award for Cancer Institute NSW

Melanoma survivors walk from Sydney to Melbourne to raise money
26 Jul 2014

Melanoma survivors walk from Sydney to Melbourne to raise money

Melanoma survivors and long-time friends Jay Allen and Andrew Rust concluded their 900km walk from Sydney to Melbourne completing their walk at the Melbourne Cricket Ground on Saturday 26 July.

The Federal Government's 2015-16 Budget announcements benefit research

The Federal Government's 2015-16 Budget announcements benefit research

The Federal Government’s 2015-16 Budget was announced this week with a boost for medical research funding. 

Melanoma Essentials eBook offered for Free during EADO and GAC (PDF)

Melanoma Essentials eBook offered for Free during EADO and GAC

It's 'Game On Mole' this summer!

It's 'Game On Mole' this summer! - Copy

All Australians are urged to join the fight against melanoma this summer. 

It's 'Game On Mole' this summer!

All Australians are urged to join the fight against melanoma this summer. 

Tags: melanoma
Sunrise features inspiring story of MIA patient

Sunrise features inspiring story of MIA patient

Melanoma Institute Australia (MIA) patient Tara Moran and her seven year old daughter Olivia, who is fundraising for MIA, have been in the national media spotlight this week. 

Dr James Wilmott wins award for Outstanding Cancer Research

Dr James Wilmott wins award for Outstanding Cancer Research

Dr James Wilmott was awarded the Wildfire Award at this year's Cancer Institute NSW's Premier Awards for Outstanding Cancer Research.

First patient recruited to the EAGLE FM Trial

First patient recruited to the EAGLE FM Trial

Evaluation of Groin Lymphadenectomy Extent for Metastatic Melanoma (EAGLE FM) clinical trial has recruited its first patient.  

Tune into Jay's Longest Melanoma March Channel 10 documentary

Tune into Jay's Longest Melanoma March Channel 10 documentary - Copy

Jay's Longest Melanoma March documentary is screening this Sunday 22 September at 1pm (AEST) on Channel 10, capturing behind the scenes of the 2000km walk, Adelaide to Sydney in 50 days. Uniting to end melanoma.

Overcoming resistance to immunotherapy.

Overcoming resistance to immunotherapy. - Copy

New research takes on major challenge to improving survival in melanoma.